Pham Quang X
Cadrenal Therapeutics, Inc. Common Stock · CEO and Chairman
Pham Quang X is listed in filings as CEO and Chairman at Cadrenal Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Cadrenal Therapeutics, Inc. Common Stock (CVKD). The current snapshot covers public activity from Jan 24, 2025 to Jun 5, 2026. Reported amounts are shown as $9.1K to $9.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.